Cyproterone acetate Prescribing at CRESCENT SURGERY
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
12
Total Quantity
322
NHS Cost
£371
vs National Avg
+9.3%
CRESCENT SURGERY prescribed 12 items of Cyproterone acetate over the last 12 months at a cost of £371 to the NHS. This is 9.3% above the national average prescribing rate. Cyproterone acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 12 |
|---|---|
| Total Quantity | 322 |
| Total NHS Cost | £371 |
| Presentations | 2 different forms |
| vs National Average | +9.3% |
Cyproterone acetate Prescribing Comparison
| This practice | 12 items |
|---|---|
| National average per practice | 11 items |
| Difference | +9.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.